PRE
Prenetics Global LtdNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$285.10M
P/E Ratio
—
EPS
$-2.46
Beta
0.15
52W High
$23.63
52W Low
$5.58
50-Day MA
$18.35
200-Day MA
$15.33
Dividend Yield
—
Profit Margin
-40.80%
Forward P/E
—
PEG Ratio
0.00
About Prenetics Global Ltd
Prenetics Global Ltd (PRE) is a leading health technology innovator specializing in advanced genetic and diagnostic testing solutions that empower both consumers and healthcare providers with essential health insights. The company has experienced robust international expansion, supported by strategic partnerships and a relentless focus on research and development. Positioned at the forefront of personalized medicine, Prenetics is well-equipped to meet the growing demand for accessible and actionable health information, making it a notable investment opportunity within the evolving healthcare sector.
Fundamentals
| Revenue (TTM) | $92.39M |
| Gross Profit (TTM) | $48.79M |
| EBITDA | $-37.19M |
| Operating Margin | -37.20% |
| Return on Equity | -22.10% |
| Return on Assets | -11.40% |
| Revenue/Share (TTM) | $6.58 |
| Book Value | $10.89 |
| Price-to-Book | 1.82 |
| Price-to-Sales (TTM) | 3.09 |
| EV/Revenue | 2.42 |
| EV/EBITDA | 0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 248.60% |
| Shares Outstanding | $15.42M |
| Float | $11.92M |
| % Insiders | 13.82% |
| % Institutions | 12.83% |
Historical Volatility
HV 10-Day
97.48%
HV 20-Day
82.73%
HV 30-Day
69.96%
HV 60-Day
82.06%
HV Rank
21.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($31.25 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026